Proteins

Olon Opens New Proteins Manufacturing Site in Italy

Olon Biotech, a division of Italian API producer Olon, has inaugurated a new facility for the industrial-scale production of proteins from alternative sources at its site in Settimo, Italy. Olon pegged the investment in the new plant at €70 million.

Germany’s Merck Buys Erbi Biosystems

Germany’s Merck has acquired Erbi Biosystems, a developer of the 2 ml micro-bioreactor platform technology known as the Breez. Financial terms were not disclosed. The company is based in the US state of Massachusetts.

Trends in Chemical & Pharmaceutical Research

Bachem and GlyTech announce co-promotion agreement

DSM to Fold Pharma Arm into Venture with Private Equity Firm

Value Over Price

ExpreS2ion Biotechnologies and Oxford's Jenner Institute Enter Licensing Agreement

Nomad Receives €1.2 Million Grant from Saxony-Anhalt

Therapeutic Proteins: Strategies to Modulate Their Plasma Half-lives

Chemical Distribution: Three Attractive Markets

Sustainability All Along The Value Chain

DSM Biologics to Acquire Rhobust Technology from Upfront Chromatography